Treatment of indolent NHL by office-based haematologists in Germany: R-bendmustine replaces R-CHOP as “Standard of Care.” 2. Juni 2013 Knauf, W., Abenhardt, W., Nusch, A., Grugel, R., Marschner, N., 2013. Hematol Oncol 31 (Suppl. I)(Abstract 467), 248. doi:10.1002/hon.2059 Abstract Treatment of Elderly Patients with CLL: Does Bendamustine Replace Chlorambucil as “Standard of Care”? Knauf, W., Abenhardt, W., Nusch, A., Grugel, R., Marschner, N., 2013. Hematol Oncol 31 (Suppl. I)(Abstract 372), 219. doi:10.1002/hon.2059 Abstract… Weiterlesen Therapy of relapsed/ refractory multiple myeloma with a combination of Lenalidomide plus Dexamethasone: First interim analysis of the non-interventional study “Revlimid.” Knauf, W., Aldaoud, A., Groschek, M., Teichmann, B., Harde, J., Hasskarl, J., 2013. Onkologie 36 (suppl. 7)(P532), 155. doi:10.1159/000356365 Abstract… Weiterlesen